Age-Dependent Development of Metabolic Derangement and Effects of Intervention with Pioglitazone in Zucker Diabetic Fatty Rats

Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity

Yukio Arita, Shinji Kihara, Noriyuki Ouchi et al. · Biochemical and Biophysical Research Communications · 1999 · 4.8K citations

Obesity, Metabolic Syndrome, Metabolic Disorder +8

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Toshimasa Yamauchi, Junji Kamon, Yasuhiko Minokoshi et al. · Nature Medicine · 2002 · 4.2K citations

Obesity, Biochemistry, Amp-activated Protein Kinase +9

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Steven E. Kahn, Steven M. Haffner, Mark Heise et al. · New England Journal of Medicine · 2006 · 2.9K citations

U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease

Diabetes · 1995 · 1.9K citations

Glucose Control, Type Ii, Obesity +16

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

The Lancet · 2006 · 1.7K citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +6